Epigenomics AG, DE000A11QW50

Epigenomics AG, DE000A11QW50

23.06.2017 - 11:14:44

Epigenomics AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Notification of Major Holdings

1. Details of issuer Epigenomics AG Geneststraße 5 10829 Berlin Germany 2. Reason for notification   Acquisition/disposal of shares with voting rights X Acquisition/disposal of instruments   Change of breakdown of voting rights   Other reason: 3. Details of person subject to the notification obligation Name: City and country of registered office: Mr Yong Yu 4. Names of shareholder(s) holding directly 3% or more voting rights, if different from 3.Cathay Fortune International Company Limited 5. Date on which threshold was crossed or reached 19 Jun 2017 6. Total positions   % of voting rights attached to shares (total of 7.a.) % of voting rights through instruments (total of 7.b.1 + 7.b.2) total of both in % (7.a. + 7.b.) total number of voting rights of issuer Resulting situation 5.11 % 14.29 % 14.29 % 22735260 Previous notification 5.06 % 18.90 % 18.90 % / 7. Notified details of the resulting situation a. Voting rights attached to shares (Sec.s 21, 22 WpHG) ISIN absolute in %   direct (Sec. 21 WpHG) indirect (Sec. 22 WpHG) direct (Sec. 21 WpHG) indirect (Sec. 22 WpHG) DE000A11QW50 0 1161139 0 % 5.11 % Total 1161139 5.11 % b.1. Instruments according to Sec. 25 para. 1 No. 1 WpHG Type of instrument Expiration or maturity date Exercise or conversion period Voting rights absolute Voting rights in % %     Total % b.2. Instruments according to Sec. 25 para. 1 No. 2 WpHG Type of instrument Expiration or maturity date Exercise or conversion period Cash or physical settlement Voting rights absolute Voting rights in % Rollover contribution obligation Physical 3249824 14.29 %       Total 3249824 14.29 % 8. Information in relation to the person subject to the notification obligation  Person subject to the notification obligation is not controlled and does itself not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer (1.). X Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity: Name % of voting rights (if at least held 3% or more) % of voting rights through instruments (if at least held 5% or more) Total of both (if at least held 5% or more) Yong Yu % % % Cathay Fortune Corp. % % % Cathay Fortune International Company Limited 5.11 % % 5.11 % Eagle Noble Limited % % % Mass Elite Limited % % % Summit Hero Limited % % % Summit Hero Holding GmbH % 14.29 % 14.29 % 9. In case of proxy voting according to Sec. 22 para. 3 WpHGDate of general meeting: Holding position after general meeting: % (equals voting rights) 10. Other explanatory remarks:No aggregation of voting rights attached to shares and instruments as voting rights attached to shares are also included in notified instruments. 

23.06.2017 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de

Language: English

Company: Epigenomics AG Geneststraße 5 10829 Berlin

Germany Internet: www.epigenomics.com   End of News DGAP News Service

585757  23.06.2017 

@ dgap.de